網膜症(Retinopathy):世界の治験レビュー2014年下半期版...市場調査レポートについてご紹介

【英文タイトル】Retinopathy Global Clinical Trials Review, H2, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Retinopathy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Retinopathy to Ophthalmology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Retinopathy to Ophthalmology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Retinopathy 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Retinopathy Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
SIFI S.p.A 32
Clinical Trial Overview of SIFI S.p.A 32
Shire Plc 33
Clinical Trial Overview of Shire Plc 33
Mednax, Inc. 34
Clinical Trial Overview of Mednax, Inc. 34
Insmed Incorporated 35
Clinical Trial Overview of Insmed Incorporated 35
Gene Signal International SA 36
Clinical Trial Overview of Gene Signal International SA 36
EyeGene, Inc. 37
Clinical Trial Overview of EyeGene, Inc. 37
AstraZeneca PLC 38
Clinical Trial Overview of AstraZeneca PLC 38
Clinical Trial Overview of Top Institutes / Government 39
National Eye Institute 39
Clinical Trial Overview of National Eye Institute 39
Eunice Kennedy Shriver National Institute of Child Health and Human Development 40
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 40
Nagoya University 41
Clinical Trial Overview of Nagoya University 41
Manhattan Eye Ear & Throat Hospital 42
Clinical Trial Overview of Manhattan Eye Ear & Throat Hospital 42
Azienda Ospedaliero-Universitaria Meyer 43
Clinical Trial Overview of Azienda Ospedaliero-Universitaria Meyer 43
Dr. Sami Ulus Children’s Hospital 44
Clinical Trial Overview of Dr. Sami Ulus Children’s Hospital 44
Weill Cornell Medical College 45
Clinical Trial Overview of Weill Cornell Medical College 45
Islamic Azad University of Tabriz 46
Clinical Trial Overview of Islamic Azad University of Tabriz 46
The Children’s Hospital of Philadelphia 47
Clinical Trial Overview of The Children’s Hospital of Philadelphia 47
Kansai Medical University 48
Clinical Trial Overview of Kansai Medical University 48
Five Key Clinical Profiles 49
Appendix 66
Abbreviations 66
Definitions 66
Research Methodology 67
Secondary Research 67
About GlobalData 68
Contact Us 68
Disclaimer 68
Source 68


【レポート販売概要】

■ タイトル:網膜症(Retinopathy):世界の治験レビュー2014年下半期版
■ 英文:Retinopathy Global Clinical Trials Review, H2, 2014
■ 発行日:2014年12月31日
■ 調査会社:GlobalData
■ 商品コード:GDHC2518CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。